Clinical Trial Update: Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health [NA]

View source ↗

Summary

A Massachusetts General Hospital-led clinical trial evaluating polygenic risk-based detection of subclinical coronary atherosclerosis and changes in cardiovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Coronary Artery Disease | NA | Status: RECRUITING